Future of Immunology Berlin 

Meta menu:

From here, you can access the Emergencies page, Contact Us page, Accessibility Settings, Language Selection, and Search page.

  • Go to Emergencies.
  • Contact us:

    Campus Charité Mittec/o Institute of Neuropathology, Charitéplatz 1 (local address:Virchowweg 15)
    10117 Berlin

  • Accessibility:
    Contrast Settings Change contrast
    Font size
    Font size bigger: STRG+ Font size smaller: STRG-

    You can enlarge or reduce the browser window. Please use CTRL and + to zoom in or CTRL and - to zoom out. Press CTRL and 0 to reset your browser window to normal size.

Open Menu

What is the Symposium all about?

Immunological research at the highest level has a long tradition at Charité -Universitätsmedizin Berlin and represents a major research focus. In the coming years, the core departments of immunology are facing a generation change at the leadership level, which gives reason to think about strategic and structural amendments to consolidate Charité’s role as a leading institution in the field of immunology – both in basic and clinical translational research. With its broad overlap to other research areas, the field of immunology plays a special role requiring interdisciplinary work and inter-organization networking. A unique characteristic is the close networking of Charité researchers with their university and non-university partners in Berlin, which enables a synergistic combination of excellent basic research and clinical research. As of today, immunological research at the Charité is embedded into a network of institutions including the German Rheumatism Research Centre (DRFZ), the Max-Delbrück Center of Molecular Medicine (MDC), the Max-Planck-Institute of Infection Biology and the Robert-Koch-Institute. We are seeking to make use of this excellent research potential and infrastructure even more intensively in the future.

Together with the newly formed Scientific Advisory Board (SAB) consisting of Drs. Erika Pearce (Freiburg, Germany), Eric Vivier (Marseille, France), Ton Schumacher (Amsterdam, Netherlands) and Frederic Geissmann (New York, USA), we have the ambitious goal of creating optimal conditions for immunological research at the Charité to be carried out at the highest international level in the future. 

To jump-start this process, we have organized a three day symposium ‘Future of Immunology @ Berlin’ which shall serve as an interactive platform to exchange ideas, concepts and visions how to evolve immunology in Berlin in the next decades. The symposium will take place from November 21-23, 2019 in Berlin at the Institute of Anatomy (Waldeyer-Haus), Charité Campus Mitte, Philippstr. 12, 10115 Berlin

Organizing Committee:

Frank Heppner (Department of Neuropathology, Charité-Universitätsmedizin Berlin), Andreas Diefenbach (Institute of Microbiology, Infectious Diseases and Immunology, Charité-Universitätsmedizin Berlin), Klaus Rajewsky (Immune Regulation and Cancer, Max-Delbrück-Center for Molecular Medicine (MDC)) and Reinhold E. Schmidt (Deutsches Rheuma-Forschungszentrum Berlin (DRFZ), Leibniz-Gemeinschaft)


The Scientific Advisory Board

Frederic Geissmann (Immunology Program, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York)

Ton Schumacher  (The Netherlands Cancer Institute, Leiden University Medical Center)

Eric Vivier (Centre d'Immunologie de Marseille-Luminy)

Invited Speakers

Andrea Ablasser (Global Health Institute, Swiss Federal Polytechnic School of Lausanne)

Burkhard Becher (Institute of Experimental Immunology-Inflammation Research, University of Zurich)

Simon Fillatreau (Institut Necker-Enfants Malades, Paris)

Thomas Gebhardt (The Peter Doherty Insitute, University of Melbourne)

Melanie Greter (Institute for Experimental Immunology, University of Zurich)

Florian Greten (Institute for Tumor Biology and Experimental Therapy, Georg Speyer Haus Frankfurt a.M.)

Bodo Grimbacher (Centre for Chronic Immunodeficiency, University Clinic Freiburg)

Mathias Heikenwälder (Chronic Inflammation and Cancer, German Cancer Research Center, Heidelberg)

Susanne Herold (Medical Clinic II, Infectiology, University of Gießen Lung Center)

Axel Kallies (The Peter Doherty Institute, University of Melbourne)

Florian Klein (Institute of Virology, University of Köln)

Gerhard Krönke (Medicine 3, University Clinic Erlangen)

Gioacchino Natoli (Biochemistry, Humanitas University Milan)

Manolis Pasparakis (Institute of Genetics, University of Köln)

Alexander Scheffold (Institute of Immunology, University Clinic Schleswig-Holstein)

Georg Schett (Medicine 3, University Clinic Erlangen)

Andrea Schietinger (Immunology Program, Memorial Sloan Kettering Cancer Center, New York)

Katja Simon (Kennedy Institute of Rheumatology, University of Oxford)

Reinhard Voll (Department of Rheumatology and Clinical Immunology, University Clinic Freiburg)

Hedda Wardemann (Department of B-cell Immunology, German Cancer Research Center, Heidelberg)

Claudia Waskow (Regeneration in Hematopoiesis: Immunology of Ageing, Leibniz Institute for Age Research, Jena)

Dietmar Zehn (Weihenstephan Science Center for Nutrition, Land Use and Environment, Technical University München)

Speakers Charité-Universitätsmedizin Berlin

Thomas Blankenstein (Institute for Immunology)

Gerd-Rüdiger Burmester (Department of Rheumatology and Clinical Immunology)

Julia Polansky-Biskup  (BIH-Center for Regenerative Therapies (BCRT))

Andreas Radbruch (Deutsches Rheuma-Forschungszentrum Berlin (DRFZ), Leibniz-Gemeinschaft)

Chiara Romagnani (Deutsches Rheuma-Forschungszentrum Berlin (DRFZ), Leibniz-Gemeinschaft)

Leif-Erik Sander (Deptartment of Infectious Diseases and Respiratory Medicine)

Norbert Suttorp (Deptartment of Infectious Diseases and Respiratory Medicine)

Antigoni Triantafyllopoulou (Department of Rheumatology and Clinical Immunology)

Hans-Dieter Volk (Institute of Medical Immunology, BIH-Center for Regenerative Therapies (BCRT))

Gerald Willimsky (Institute of Immunology)